Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SINHA, Y. N.
Right arrow Articles by VANDERLAAN, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SINHA, Y. N.
Right arrow Articles by VANDERLAAN, W. P.
Agricola
Right arrow Articles by SINHA, Y. N.
Right arrow Articles by VANDERLAAN, W. P.

Biology of Reproduction, Vol 21, 473-481, Copyright © 1979 by Society for the Study of Reproduction

Gonadal Regulation of Prolactin and Growth Hormone Secretion in the Mouse

Y. N. SINHA 1, M. A. WICKES 1, C. B. SALOCKS 1, , and W. P. VANDERLAAN 1

1 Lutcher Brown Center for Diabetes and Endocrinology, Scripps Clinic and Research Foundation, La Jolla, California 92037


The influences of castration and of subsequent replacement therapy with gonadal hormones on the secretion of prolactin (PRL) and growth hormone (GH) in male and female mice were investigated. Long term castration in female mice significantly reduced basal and perphenazine-induced PRL levels in the serum and PRL concentrations in the pituitary gland. Treatment with a moderate dose (1 µg/day) of estradiol benzoate (EB) for several weeks increased PRL levels in the pituitary gland and serum, but the release of PRL in response to perphenazine was not augmented. A large dose of EB(20 µg/day), on the other hand, resulted in a smaller increase in pituitary concentrations, little or no increase in basal serum levels and complete abolition of perphenazine-induced PRL release, suggesting that high doses of EB are detrimental to the release of PRL.

In male mice, castration had little or no effect on PRL levels in the pituitary gland or on basal concentrations in serum, but it significantly reduced perphenazine-induced release of PRL. Administration of testosterone (0.5 mg/day) only marginally enhanced pituitary and serum concentrations of PRL, whereas EB injection (1 µg/day) increased serum and pituitary PRL concentrations severalfold. However, neither testosterone nor EB treatment of orchidectomized males could cause serum PRL concentrations to rise after injection of perphenazine to levels equivalent to those in intact females. This suggests that the sex difference in the control of PRL secretion in adult mice involves the pituitary-hypothalamic system rather than the gonad.

Concentrations of GH in the pituitary glands and sera of female mice increased following castration, whereas administration of EB (1 µg/day) decreased basal levels of GH in serum and prevented the usual postcastration rise in serum and pituitary GH. In male mice, in contrast, castration reduced pituitary GH concentrations but had no marked influence on serum GH. Administration of testosterone (0.5 mg/day), in turn, increased pituitary GH concentrations, with no appreciable influence on serum GH. These results indicate that the female gonad exerts a net inhibitory influence on GH secretion in female mice, whereas, although essential for maintaining normal levels in the pituitary gland, the male gonad has little influence on the circulating levels of GH in male mice.

Note:
ACKNOWLEDGMENTS Supported by grants CA-14025 and CA-18664, awarded by the National Cancer Institute, DHEW. This is Publication No. 7 from the Lutcher Brown Center for Diabetes and Endocrinology. A preliminary report of part of this work has appeared in abstract form (Program 59th Meeting, Endocrine Society, 1977, p. 224).

Submitted on March 14, 1978
Accepted on May 8, 1979




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. F. Couse, M. M. Yates, V. R. Walker, and K. S. Korach
Characterization of the Hypothalamic-Pituitary-Gonadal Axis in Estrogen Receptor (ER) Null Mice Reveals Hypergonadism and Endocrine Sex Reversal in Females Lacking ER{alpha} But Not ER{beta}
Mol. Endocrinol., June 1, 2003; 17(6): 1039 - 1053.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the Society for the Study of Reproduction.